DiaResQ listed among leading healthcare innovations
DiaResQ is designed to meet the dietary needs of children who have infectious diarrhea, making it a nutritional intervention that repairs a child’s natural defenses and encourages intestinal rebuilding.
There were only 12 innovations selected in the newborn, child and maternal health categories.
DiaResQ was designed as the company’s flagship product to treat pediatric infectious diarrhea. It has been included among the 30 leading healthcare innovations that show promise in transforming worldwide health by 2030 in Reimagining Global Health, which is the first report of the Innovation Countdown 2030 initiative. The goal of the initiative is to help speed the progress of the health industry toward attaining the new health targets that the U.N. Sustainable Development Goals proposes.
“We are truly honored to have DiaResQ included in the Innovation Countdown 2030’s Reimagining Global Health report,” Mark A. Braman, president and CEO of PanTheryx, said. “This recognition validates what we have always believed -- that DiaResQ is truly a breakthrough nutritional intervention for pediatric diarrhea with the potential to greatly improve the wellbeing and quality of life of millions of children and their families worldwide.”